Your browser doesn't support javascript.
loading
Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study.
Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Yeo, Belinda; Malik, Laeeq; Greenberg, Sally; Anton, Angelyn; Nott, Louise; Barnett, Frances; Collins, Ian M; Lombard, Janine; Nottage, Michelle; Sahu, Arvind; Torres, Javier; Gibbs, Peter; Lok, Sheau Wen.
Affiliation
  • Tung I; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Victoria, Australia; Department of Medical Oncology, Eastern Health, Victoria, Australia; Department of Medical Oncology, Goulburn Valley Health, Victoria, Australia. Electronic address: iris.tung12@gmail.com.
  • Moldovan C; Department of Medical Oncology, Royal Hobart Hospital, Tasmania, Australia.
  • Wong V; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Victoria, Australia; Department of Medical Oncology, Ballarat Health Services, Victoria, Australia.
  • De Boer R; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Victoria, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Victoria, Australia; Department of Medical Oncology, Epworth Freemasons, Victoria, Australia.
  • Yeo B; Department of Medical Oncology, Austin Health, Victoria, Australia.
  • Malik L; Department of Medical Oncology, Canberra Hospital, Australian Capital Territory, Australia.
  • Greenberg S; Department of Medical Oncology, Western Health, Victoria, Australia.
  • Anton A; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Victoria, Australia; Department of Medical Oncology, Eastern Health, Victoria, Australia.
  • Nott L; Department of Medical Oncology, Royal Hobart Hospital, Tasmania, Australia.
  • Barnett F; Department of Medical Oncology, Northern Health, Victoria, Australia.
  • Collins IM; Department of Medical Oncology, Southwest Healthcare, Victoria, Australia.
  • Lombard J; Department of Medical Oncology, The University of Newcastle, New South Wales, Australia.
  • Nottage M; Department of Medical Oncology, Royal Brisbane and Women's Hospital, Queensland, Australia.
  • Sahu A; Department of Medical Oncology, Goulburn Valley Health, Victoria, Australia.
  • Torres J; Department of Medical Oncology, Goulburn Valley Health, Victoria, Australia.
  • Gibbs P; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Victoria, Australia; Department of Medical Oncology, Western Health, Victoria, Australia.
  • Lok SW; Personalised Oncology Division, Walter and Eliza Hall Institute of Medical Research, Victoria, Australia; Department of Medical Oncology, Peter MacCallum Cancer Centre, Victoria, Australia.
Clin Breast Cancer ; 22(7): e764-e772, 2022 10.
Article in En | MEDLINE | ID: mdl-35941066
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms / Maytansine Type of study: Prognostic_studies Limits: Female / Humans Country/Region as subject: Oceania Language: En Journal: Clin Breast Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Breast Neoplasms / Maytansine Type of study: Prognostic_studies Limits: Female / Humans Country/Region as subject: Oceania Language: En Journal: Clin Breast Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: